Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT

Journal of Surgical Oncology

Volumn 98, Issue 6, 2008, Pages 438-443

  Li, Jun ^a   Kuehl, Hilmar ^a   Grabellus, Florian ^a   Müller, Stephan P ^a   Radunz, Sonia ^a   Antoch, Gerald ^a   Nadalin, Silvio ^a   Broelsch, Christoph E ^a   Gerken, Guido ^a   Paul, Andreas ^a   Kaiser, Gernot M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Hilar cholangiocarcinoma; PET CT; Tumour staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISTANT METASTASIS; FEMALE; HILAR CHOLANGIOCARCINOMA; HUMAN; LAPAROTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55749088949     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21136     Document Type: Article

References (36)

1. Lang H, Kaiser GM, Zopf T, et al.: Surgical therapy of hilar cholangiocarcinoma. Chirurg 2006;77:325-334.
2. Klatskin G: Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. an unusual tumor with distinctive clinical and pathological features. Am J Med 1965;38:241-256.
3. Khan SA, Thomas HC, Davidson BR: Taylor-Robinson SD: Cholangiocarcinoma. Lancet 2005;366:1303-1314.
4. Kaiser GM, Oldhafer KJ, Zhang HW, et al.: Treatment of nonresectable proximal bile duct carcinoma using intraoperative radiotherapy combined with hepatojejunostomy. J Surg Oncol 2002;81:55-57.
5. Khan AZ, Makuuchi M: Trends in the surgical management of Klatskin tumours. Br J Surg 2007;94:393-394.
6. Fritscher-Ravens A, Bohuslavizki KH, Broering DC, et al.: FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 2001;22:1277-1285.
7. Jarnagin WR, Fong Y, DeMatteo RP, et al.: Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-517.
8. Kluge R, Schmidt F, Caca K, et al.: Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001;33:1029-1035.
9. Vogl TJ, Schwarz WO, Heller M, et al.: Staging of Klatskin tumours (hilar cholangiocarcinomas): Comparison of MR cholangiography, MR imaging, and endoscopic retrograde cholangiography. Eur Radiol 2006;16:2317-2325.
10. Reinhardt MJ, Strunk H, Gerhardt T, et al.: Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: Preliminary results for 22 patient studies. J Nucl Med 2005;46:1158-1163.
11. Zech CJ, Schoenberg SO, Reiser M, et al.: Cross-sectional imaging of biliary tumors: Current clinical status and future developments. Eur Radiol 2004;14:1174-1187.
12. Abouzied MM, Crawford ES: Nabi HA: 18F-FDG imaging: Pitfalls and artifacts. J Nucl Med Technol 2005;33:145-155.
13. Kuehl H, Veit P, Rosenbaum SJ, et al.: Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen. J Nucl Med 2007;48:45S-57S.
14. Antoch G, Saoudi N, Kuehl H, et al.: Accuracy of whole-body dualmodality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: Comparison with CTand PET. J Clin Oncol 2004;22:4357-4368.
15. Sobin LH, Wittekind CH: TNM classification of malignant tumours. West Sussex:John Wiley 2002.
16. Huang SC: Anatomy of SUV. Standardized uptake value. Nucl Med Biol 2000;27:643-646.
17. Hawkins RA, Choi Y, Huang SC, et al.: Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med 1992;33:339-344.
18. Kapoor V, McCook BM, Torok FS: An introduction to PET-CT imaging. Radiographics 2004;24:523-543.
19. Bismuth H, Corlette MB: Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975;140:170-178.
20. Neuhaus P, Jonas S, Bechstein WO, et al.: Extended resections for hilar cholangiocarcinoma. Ann Surg 1999;230:808-818.
21. Kosuge T, Yamamoto J, Shimada K, et al.: Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999;230:663-671.
22. Siqueira E, Schoen RE, Silverman W, et al.: Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc 2002;56:40-47.
23. Glasbrenner B, Ardan M, Boeck W, et al.: Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 1999;31:712-717.
24. Jailwala J, Fogel EL, Sherman S, et al.: Triple-tissue sampling at ERCP inmalignant biliary obstruction. Gastrointest Endosc 2000;51:383-390.
25. Yeh TS, Jan YY, Tseng JH, et al.: Malignant perihilar biliary obstruction: Magnetic resonance cholangiopancreatographic findings. Am J Gastroenterol 2000;95:432-440.
26. Feydy A, Vilgrain V, Denys A, et al.: Helical CTassessment in hilar cholangiocarcinoma: Correlation with surgical and pathologic findings. Am J Roentgenol 1999;172:73-77.
27. Kim YJ, Yun M, Lee WJ, et al.: Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 2003;30:1467-1472.
28. Keiding S, Hansen SB, Rasmussen HH, et al.: Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998;28:700-706.
29. Petrowsky H, Wildbrett P, Husarik DB, et al.: Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 2006;45:43-50.
30. Kato T, Tsukamoto E, Kuge Y, et al.: Clinical role of (18)FFDG PET for initial staging of patients with extrahepatic bile ductcancer. Eur J Nucl Med Mol Imaging 2002;29:1047-1054.
31. Unno M, Okumoto T, Katayose Y, et al.: Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg 2007;14:434-440.
32. Nelson RC, Chezmar JL, Hoel MJ, et al.: Peritoneal carcinomatosis: Preoperative CT with intraperitoneal contrast material. Radiology 1992;182:133-138.
33. Turlakow A, Yeung HW, Salmon AS, et al.: Peritoneal carcinomatosis: Role of (18)F-FDG PET. J Nucl Med 2003;44:1407-1412.
34. Selzner M, Hany TF, Wildbrett P, et al.: Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004;240:1027-1034.
35. Heinrich S, Goerres GW, Schafer M, et al.: Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 2005;242:235-243.
36. Gupta NC, Graeber GM, Bishop HA: Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1cm), intermediate (1-3 cm), and large (>3 cm) lymph node lesions. Chest 2000;117:773-778.